ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
U.S. Court of Appeals Upholds District Court’s Decision to Invalidate Ampyra Patents
September 12, 2018Acorda Therapeutics announced that the United States Court of Appeals for the Federal Circuit, by a 2-1 vote, has upheld the United States District Court for the District of Delaware’s decision to invalidate four Ampyra patents. This decision affirms the -
Activist pushes Acorda to sell, figuring pipeline's too risky to offset Ampyra loss
August 08, 2017A New York hedge fund, Scopia Capital Management, wants Acorda to put itself up for sale
Pharma Sources Insight January 2025
